Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Babsmoneyon Nov 14, 2018 7:13pm

40 Views

Post# 28976607

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:NF.CSE. BIDS HERE IS THE SPIKE

If the Farm Bill is passed then this will pick up a bit quicker. But it has nothing on Tilrey, not saying it’s going to a 1$ right away but .35-.40 in next few months will be more realistic.

Bullboard Posts

A Look into the Future of Chronic Pain Management